Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Sawada

Showing results (11-20 of 77) with videos related to

Pageof 8
Sort By:
Experimental Hematology|July 1, 1980
Hemopoietic support capacity of W/WV femurs and tibiasS S Adler, U Sawada, F E Trobaugh
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2000
[Phenotypic classification of malignant lymphoma]Y Kaneita, K Yasukawa, Y Kura, et al.
Internal Medicine (Tokyo, Japan)|January 1, 1995
Liver damage after danazol and glucocorticoids for chronic idiopathic thrombocytopenic purpura (ITP)A Sakuma, I Tsuboi, K Morimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1987
[Treatment of Hodgkin's disease in Japan--a retrospective study on 70 cases at 3 institutes]U Sawada, T Takagi, K Sampi, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Effect of Tween-80 on cell killing by etoposide in human lung adenocarcinoma cellsI Tsujino, T Yamazaki, M Masutani, et al.
International Journal of Hematology|January 1, 1993
A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: a prospective randomized studyT Takagi, K Sampi, U Sawada, et al.
Experimental Hematology|September 1, 1978
Hemopoiesis on macrophage-coated cellulose acetate membranes (CAMS) in mice: an immunological studyU Sawada, R D Kuznetsky, F E Trobaugh, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1995
[Primary nasopharyngeal lymphoma with CD3- and CD56+ phenotype]T Saito, K Morimoto, I Mitamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1996
[A study of the significance of serum beta 2-microglobulin levels in patients with multiple myeloma--analyzes as a marker of renal dysfunction and as a marker of tumor cell mass]S Nishinarita, H Shimada, R Suzuki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 1998
[Donor leukocyte transfusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation]T Itoh, Y Hatta, T Miyajima, et al.
Pageof 8

Showing results (11-20 of 77) with videos related to

Sort By:
Pageof 8
Experimental Hematology|July 1, 1980
Hemopoietic support capacity of W/WV femurs and tibiasS S Adler, U Sawada, F E Trobaugh
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 31, 2000
[Phenotypic classification of malignant lymphoma]Y Kaneita, K Yasukawa, Y Kura, et al.
Internal Medicine (Tokyo, Japan)|January 1, 1995
Liver damage after danazol and glucocorticoids for chronic idiopathic thrombocytopenic purpura (ITP)A Sakuma, I Tsuboi, K Morimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1987
[Treatment of Hodgkin's disease in Japan--a retrospective study on 70 cases at 3 institutes]U Sawada, T Takagi, K Sampi, et al.
Cancer Chemotherapy and Pharmacology|January 29, 1999
Effect of Tween-80 on cell killing by etoposide in human lung adenocarcinoma cellsI Tsujino, T Yamazaki, M Masutani, et al.
International Journal of Hematology|January 1, 1993
A comparative study of CHOP versus MEVP (mitoxantrone, etoposide, vindesine, prednisolone) therapy for intermediate-grade and high-grade non-Hodgkin's lymphoma: a prospective randomized studyT Takagi, K Sampi, U Sawada, et al.
Experimental Hematology|September 1, 1978
Hemopoiesis on macrophage-coated cellulose acetate membranes (CAMS) in mice: an immunological studyU Sawada, R D Kuznetsky, F E Trobaugh, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|January 1, 1995
[Primary nasopharyngeal lymphoma with CD3- and CD56+ phenotype]T Saito, K Morimoto, I Mitamura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 1, 1996
[A study of the significance of serum beta 2-microglobulin levels in patients with multiple myeloma--analyzes as a marker of renal dysfunction and as a marker of tumor cell mass]S Nishinarita, H Shimada, R Suzuki, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 8, 1998
[Donor leukocyte transfusion as treatment for relapsed chronic myelogenous leukemia after allogeneic bone marrow transplantation]T Itoh, Y Hatta, T Miyajima, et al.
Pageof 8